EQS-News: Report on CPH by Research Dynamics: HY/2017 results

Nachricht vom 26.07.2017 (www.4investors.de) -

EQS Group-News: Research Dynamics / Schlagwort(e): Research Update

Report on CPH by Research Dynamics: HY/2017 results
26.07.2017 / 17:37
This report is published by Research Dynamics, an independent research boutiqueExecution on track, but higher recycling paper prices erode margins

Strong 1H 2017 sales, with top line growth in all divisions

CPH reported a healthy top line growth of 5.5% YoY for 1H2017, as sales reached CHF231.7 million, driven by higher sales volumes across all segments as well as the acquisition of China-based Jiangsu ALSIO Technology Co. Among the three segments, Chemistry reported the highest EBIT margin of 4.9%. Group EBIT stood at CHF 1.1 million in 1H2017 compared to CHF 6.0 million in 1H2016. Although the company saw substantial improvements in the top line in all three divisions, the negative impact on EBIT was mainly due to considerable higher recycling paper costs combined with lower sales volumes for the higher margin coated paper.. Further the expected start-up costs for the Chinese operation in the Packaging Division had an additional non-recurring negative impact. As a consequence, despite improved operating performance, the company's bottom line remained negative in 1H2017 with a net loss of CHF 2.2 million.

Segmental performance

Paper: The paper industry is still struggling as demand in newsprint and magazine paper declined by around 6% in 1H2017, compared to a decrease of 5% in 1H2016. The division also experienced a drop in the proportion of higher-value products sold as customers are shifting to lower cost alternatives. In spite of all these negatives, the top line at the Paper division rose by 5.1%YoY from CHF121.9 million to CHF 128.1 million in 1H2017 thanks to higher volumes. Despite the higher sales and lower fixed cost, the segment reported a loss of CHF 6.01 million at the operating level, from CHF 0.9 million in the prior year. This was mainly due to a double-digit increase in raw material cost (recycling paper). Management's focus on efficiency improvements resulted in a continued fall in carbon emissions and will further enhance the Perlen plant carbon emissions credentials.

Packaging: Net sales at the Packaging division increased by 4.7% YoY from CHF 62.6 million to CHF 65.5 million in 1H2017. The rise in sales was primarily attributable to continued growth of high-barrier film products and an increase in the volumes of uncoated mono-films sold during the period. Though the European pharmaceutical market remained stagnant in the first half of 2017, CPH was able to increase its market share in the region. The new production plant in Wujiang, China, which began operations in 2Q2016, has supported volume growth. However, the cost of raw materials such as PVC witnessed a significant increase in prices and the start-up costs for the Chinese operations impacted the results negatively. As a result of this, the Packaging division posted a slight drop in EBIT to CHF 5.5 million from CHF 6.1 million in 1H2016. The EBIT margin thus was lower at 8.4% vs. 9.8% in the prior period.

Chemistry: Segment sales surged by 8.7% YoY to CHF 38 million, supported by increased volumes coupled with a better utilization of production facilities. Revenues were also supported by the integration of China-based molecular sieve manufacturer Jiangsu ALSIO Technology Co into the division's production base. Sales of high-margin products increased, resulting in an improvement in profitability. The segment was able to post an operating profit of CHF 1.9 million, from CHF 0.5 million a year ago. EBIT margin thus improved from 1.3% to 4.9% in 1H2017. The transfer of standard molecular sieve production to China has now been completed and the new plant in Bosnia and Herzegovina is proceeding according to plan.


The group aims to increase packaging activities in emerging markets to take advantage of the growing local pharmaceutical markets. While the Chemistry division is expected to achieve similar results in 2H2017 as in the first half-year, conditions in the Paper division may remain difficult. The group targets higher net sales for FY2017 overall and a break-even EBIT result. Thanks to extraordinary income from real-estate sales, net income should be positive.

Paper: The division is not ruling out a price increase in 2H2017 for certain types of paper despite market overcapacity. While division revenues should also increase for FY2017 overall, EBIT is expected to remain negative. Efficiency enhancements continue to be on the cards.

Packaging: Transfer of orders to the Chinese production facility (from Switzerland) will drive sales growth in the Asia-Pacific region and result in margin improvement. For FY2017, the group expects to report higher net sales and an EBIT in line with prior-year level.

Chemistry: The integration of this division into a one-brand Zeochem AG (see below) will help in realizing synergies across the division which will operate from its new Swiss premises in Rüti by end of the year. New production facilities in Bosnia and Herzegovina are also expected to commence operations from 4Q2017. For FY2017, the division expects to report continued net sales growth and an EBIT margin in line with the first-half level.

Zeochem merges its Swiss-based companies

The Chemistry Division plans to merge its Swiss-based companies CU Deutero + Agro AG and Chemie Uetikon AG into Zeochem AG. By integrating the units into Zeochem AG, the group looks forward to make use of synergies in terms of better quality, logistic, marketing and sales. Following the integration, the division will trade solely under the Zeochem brand on the Swiss market. The divisions' deuterated products will be manufactured and distributed from a new site in Rüti (near Zurich) from 2018 onwards. In addition to Switzerland, Zeochem has operations in the USA and China and will add a new site in Zvornik, Bosnia and Herzegovina which will start operations in 4Q2017.

CPH Group's Packaging and Chemistry division sharpens brand profile

CPH also plans to standardize the branding of its Packaging and Chemistry Division under the brand names Perlen Packaging and Zeochem respectively. These actions are the result of a broader reappraisal of the Group's divisional branding strategy. The Group is also looking forward to rename every company based on the brand name, company's legal form and geographical location and expects to complete the process by mid-2018.

Paper Division to acquire Papierfabrik Utzenstorf AG's paper recycling business

CPH's paper division, Perlen Papier AG, will acquire Papierfabrik Utzenstorf AG's paper recycling business along with its contractual agreements with customers, suppliers and remaining paper stock for an undisclosed sum. This acquisition which is to be effective from 1 January, 2018, reflects the consolidation pressure in the Swiss newspaper industry. With this acquisition, CPH will have higher proportion of recovered paper sourced from Switzerland which should result in reduction of its raw material cost as Utzendorf Papier recovered 25% of the Swiss waste paper (recycling) from 800 communities with an annual volume of 260,000 tonnes. Utzendorf Papier has an own sorting facility for recovered paper and has agreements with hundreds of communities to collect waste paper, which ensures the sourcing also in the coming years. Post this acquisition, Perlen Papier will be Switzerland's only manufacturer of newsprint and magazine paper. Further, its production plant in Perlen will then process 500,000 tonnes of waste paper per year. They also have agreements with various communities to recover household waste papers, which ensure long term availability. Perlen Papier will also continue to operate the paper sorting facility in Utzenstorf. We believe the acquisition of the Utzenstorf recycling business and the new PM7, Europe's most advanced paper machine with capacity of 350,000 tonnes per year, will help CPH to improve margins at the lagging paper division.

Valuation and conclusion

We value CPH using DCF and relative valuation techniques. In the DCF analysis, we have reduced the market risk premium (MRP) to 9.6% from 11.2% used earlier. We have reduced the MRP as we believe the management is executing well, delivering on operational excellence in costs and quality despite the challenging environment in the Paper Division. In addition the latest Utzenstorf recycling business acquisition reduces the sourcing risk of waste paper. We have also considered a higher risk-free rate of 0.5% compared to current 10 year Government Bond yield of 0.04% as we believe it is not sustainable in the long term. Based on our input factors and valuation assumptions, we arrive at an intrinsic value of CHF 56.8 per share, giving it an upside potential of 10.9%.

On a relative basis the stock is trading at P/Sales of 0.6x, giving 52% discount to its peers based on the last three year's average. On one year forward EV/EBITDA of 9.4x CPH is trading at a 5% discount to its peers.

We believe in the medium-term stock could trade at higher multiples on account of an increased contribution of sales and operating profits expected out of the Asia-Pacific region and higher operating efficiencies from the new production facilities.

Zusatzmaterial zur Meldung:Dokument: http://n.eqs.com/c/fncls.ssp?u=MLSPIJRQTSDokumenttitel: CPH_HY17_results
Ende der Medienmitteilung

596017  26.07.2017 

PfeilbuttonOhne Depotgebühren. Mit Kosten-Airbag. Das Wertpapierdepot der MERKUR BANK.

4investors Exklusiv-Berichte und Interviews:
PfeilbuttonR-LOGITECH: „Akquisitionen liegen in unserer DNA“
PfeilbuttonMagForce: NanoTherm soll ein weltweiter Erfolg werden
PfeilbuttonCLIQ Digital AG: „Playfilms ist eine echte Erfolgsgeschichte“

Aktuelle Nachrichten aus der 4investors-Redaktion

23.03.2018 - DWS: Kein faszinierender Start
23.03.2018 - InterCard: Ergebnis gibt deutlich nach
23.03.2018 - ElringKlinger: Elektromobilität rückt in den Fokus
23.03.2018 - Indus: Vorstandschef geht
23.03.2018 - Baader Bank: Zurück in der Gewinnzone
23.03.2018 - Vectron verzeichnet Gewinneinbruch
23.03.2018 - Hamborner REIT holt sich 75 Millionen Euro
23.03.2018 - Deutsche Wohnen hebt die Dividende an
23.03.2018 - Siemens Healthineers Aktie: Spannung nach Gewinnmitnahmen - nächster Schub nach oben?
23.03.2018 - Aixtron Aktie: Vorsicht, Gefahr!


23.03.2018 - Siemens Healthineers Aktie: Spannung nach Gewinnmitnahmen - nächster Schub nach oben?
23.03.2018 - Aixtron Aktie: Vorsicht, Gefahr!
23.03.2018 - Steinhoff Aktie: Kein Ende der Talfahrt
23.03.2018 - Geely Aktie mit Intraday-Wende: Hoffnung kommt auf!
23.03.2018 - Deutsche Bank Aktie: Vorsicht, hier könnte der nächste Sturz anstehen!
23.03.2018 - Commerzbank Aktie: Der nächste Schock?
23.03.2018 - Medigene Aktie: Richtig schlechte News
22.03.2018 - 1+1 Drillisch Aktie: Ist der Selloff beendet?
22.03.2018 - Commerzbank und Deutsche Bank: Üble Sache, aber…
22.03.2018 - Commerzbank Aktie: Droht hier wegen der Deutschen Bank Schlimmeres?


23.03.2018 - RIB Software: Ein schwerer Rückschlag
23.03.2018 - Wirecard: Indien beeindruckt
23.03.2018 - 1+1 Drillisch: Wieder im Aufwärtsmodus - Kaufempfehlung
23.03.2018 - Cancom: Kaufempfehlung entfällt
23.03.2018 - RWE: Kaum Bewegung beim Kurs
23.03.2018 - Medigene: Weiteres Abwärtspotenzial
23.03.2018 - Grammer: Fragen und Unsicherheiten
23.03.2018 - RIB Software: Deutliche Kritik
23.03.2018 - Deutsche Bank: Zweischneidiger Börsengang
23.03.2018 - Paion: Kursziel sinkt nach den Zahlen


23.03.2018 - Verliert Deutschland als Handelsmacht an Bedeutung? - CMC Markets Kolumne
23.03.2018 - DAX: Die Angst vor einem Handelskrieg drückt den DAX unter 12.000 Punkte - Nord LB Kolumne
23.03.2018 - Unternehmensstimmung im Euroraum trübt sich weiter ein - Commerzbank Kolumne
23.03.2018 - DAX: Handelskrieg belastet - Donner + Reuschel Kolumne
23.03.2018 - Volkswagen Aktie: Kurzfristig weiteres Abwärtspotenzial vorhanden - UBS Kolumne
23.03.2018 - DAX: Erneuter Test der 12.000-Punkte-Marke - UBS Kolumne
22.03.2018 - Fed erhöht Zinsausblick für 2019 und 2020 - Commerzbank Kolumne
22.03.2018 - Schlechte Konjunkturdaten = fallender DAX? Nicht unbedingt! - Donner + Reuschel Kolumne
22.03.2018 - Siemens Aktie: Weiterer Kursrückgang möglich - UBS Kolumne
22.03.2018 - DAX: Zurückhaltung vor dem FED-Zinsentscheid - UBS Kolumne

All Right Reserved by minimalthemes - ©2018 Stoffels & Barck GbR